NO922426L - Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse - Google Patents
Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelseInfo
- Publication number
- NO922426L NO922426L NO92922426A NO922426A NO922426L NO 922426 L NO922426 L NO 922426L NO 92922426 A NO92922426 A NO 92922426A NO 922426 A NO922426 A NO 922426A NO 922426 L NO922426 L NO 922426L
- Authority
- NO
- Norway
- Prior art keywords
- relationships
- cleaning
- procedure
- preparation
- inhibiting properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4120510 | 1991-06-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO922426D0 NO922426D0 (no) | 1992-06-19 |
| NO922426L true NO922426L (no) | 1992-12-22 |
Family
ID=6434452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92922426A NO922426L (no) | 1991-06-21 | 1992-06-19 | Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0519433A1 (instruction) |
| JP (1) | JPH05186461A (instruction) |
| KR (1) | KR930000506A (instruction) |
| CN (1) | CN1068112A (instruction) |
| BR (1) | BR9202325A (instruction) |
| CA (1) | CA2071744A1 (instruction) |
| CZ (1) | CZ190692A3 (instruction) |
| FI (1) | FI922875A7 (instruction) |
| HU (1) | HUT61744A (instruction) |
| IE (1) | IE921995A1 (instruction) |
| MX (1) | MX9203070A (instruction) |
| NO (1) | NO922426L (instruction) |
| PL (1) | PL294870A1 (instruction) |
| ZA (1) | ZA924522B (instruction) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071895A (en) | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| RU2126794C1 (ru) | 1992-03-11 | 1999-02-27 | Нархекс Лимитед | Аминопроизводные оксо- или гидроксизамещенных гидразинов, способ их получения и фармацевтические композиции для ингибирования ретровирусной протеазы |
| US5888992A (en) | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| DE69333270T2 (de) | 1992-03-11 | 2004-08-05 | Narhex Ltd. | Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen |
| IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
| US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
| US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
| US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6133256A (en) * | 1997-04-14 | 2000-10-17 | Cor Therapeutics Inc | Selective factor Xa inhibitors |
| WO1998046627A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
| US6204268B1 (en) | 1997-04-14 | 2001-03-20 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
| US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| ECSP003707A (es) * | 1999-10-13 | 2002-05-23 | Novartis Ag | Diazepanes |
| US6399599B1 (en) | 1999-10-13 | 2002-06-04 | Novartis Ag | Substituted 2-oxo-1,4-diazacycloalkanes |
| CA2436774A1 (en) | 2001-01-30 | 2002-08-08 | R. Michael Lawrence | Sulfonamide lactam inhibitors of factor xa |
| AR047445A1 (es) * | 2004-01-23 | 2006-01-18 | Speedel Experimenta Ag | Compuestos derivados de amino alcohol con actividad inhibidora de la renina y su uso en composiciones farmaceuticas. |
| PT1756037E (pt) | 2004-01-23 | 2011-02-25 | Novartis Ag | Derivados de aminoálcoois e a sua actividade como inibidores de renina |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL81234A (en) * | 1986-01-16 | 1992-09-06 | Abbott Lab | Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them |
| GB8707412D0 (en) * | 1987-03-27 | 1987-04-29 | Fujisawa Pharmaceutical Co | Peptide compounds |
| IL87614A0 (en) * | 1987-09-16 | 1989-01-31 | Abbott Lab | Peptidylheterocycles |
| ATE165085T1 (de) * | 1987-09-29 | 1998-05-15 | Banyu Pharma Co Ltd | N-acylaminosäurederivate und deren verwendung |
| IL92011A0 (en) * | 1988-10-19 | 1990-07-12 | Abbott Lab | Heterocyclic peptide renin inhibitors |
| DE3839559A1 (de) * | 1988-11-24 | 1990-05-31 | Hoechst Ag | Renin-hemmende aminodiol-derivate |
| DE3841732A1 (de) * | 1988-12-10 | 1990-06-13 | Hoechst Ag | Dipeptid-derivate mit enzym-inhibitorischer wirkung |
| DE3913272A1 (de) * | 1989-04-22 | 1990-10-25 | Hoechst Ag | Dipeptid-derivate mit enzym-inhibitorischer wirkung |
-
1992
- 1992-06-11 PL PL29487092A patent/PL294870A1/xx unknown
- 1992-06-17 EP EP92110244A patent/EP0519433A1/de not_active Withdrawn
- 1992-06-18 FI FI922875A patent/FI922875A7/fi unknown
- 1992-06-19 HU HU9202062A patent/HUT61744A/hu unknown
- 1992-06-19 BR BR929202325A patent/BR9202325A/pt not_active Application Discontinuation
- 1992-06-19 KR KR1019920010653A patent/KR930000506A/ko not_active Withdrawn
- 1992-06-19 MX MX9203070A patent/MX9203070A/es unknown
- 1992-06-19 CA CA002071744A patent/CA2071744A1/en not_active Abandoned
- 1992-06-19 NO NO92922426A patent/NO922426L/no unknown
- 1992-06-19 ZA ZA924522A patent/ZA924522B/xx unknown
- 1992-06-19 JP JP4160476A patent/JPH05186461A/ja active Pending
- 1992-06-19 CZ CS921906A patent/CZ190692A3/cs unknown
- 1992-06-20 CN CN92104887A patent/CN1068112A/zh active Pending
- 1992-07-01 IE IE199592A patent/IE921995A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IE921995A1 (en) | 1992-12-30 |
| CZ190692A3 (en) | 1993-01-13 |
| PL294870A1 (instruction) | 1993-02-08 |
| KR930000506A (ko) | 1993-01-15 |
| JPH05186461A (ja) | 1993-07-27 |
| HUT61744A (en) | 1993-03-01 |
| MX9203070A (es) | 1992-12-01 |
| CN1068112A (zh) | 1993-01-20 |
| ZA924522B (en) | 1993-02-24 |
| HU9202062D0 (en) | 1992-10-28 |
| EP0519433A1 (de) | 1992-12-23 |
| CA2071744A1 (en) | 1992-12-22 |
| FI922875A0 (fi) | 1992-06-18 |
| FI922875L (fi) | 1992-12-22 |
| FI922875A7 (fi) | 1992-12-22 |
| BR9202325A (pt) | 1993-01-19 |
| NO922426D0 (no) | 1992-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO922426D0 (no) | Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse | |
| FI945281A7 (fi) | Heterosykliset yhdisteet, niiden valmistus ja käyttö | |
| FI934426A7 (fi) | Tiatsolidiinidionijohdokset, niiden valmistus ja käyttö | |
| NO921652D0 (no) | Keramisk skumlegeme, fremgangsmaate til dets fremstilling og anvendelse av legemet i en oljelense | |
| NO940989D0 (no) | Triazolkinoksalin-1,4-dioner og deres fremstilling og anvendelse | |
| NO940027L (no) | Fremgangsmaate for fremstilling av derivater av B-fenylisorerin og derivatenes anvendelse | |
| NO953673D0 (no) | [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse | |
| FI934680A7 (fi) | Aryylimorfoliini, valmistus ja käyttö | |
| NO893826L (no) | Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater. | |
| FI954229L (fi) | Heterosykliset yhdisteet, niiden käyttö ja valmistus | |
| NO900643L (no) | Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater. | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| DK222488D0 (da) | Glycopeptider med enkephalinase-haemmende virkning,deres fremstilling og anvendelse | |
| DK73091D0 (da) | Quinoxalinforbindelser, deres fremstilling og anvendelse | |
| NO921086D0 (no) | Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner | |
| NO922992D0 (no) | Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse | |
| NO905543D0 (no) | Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer. | |
| NO924516D0 (no) | Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler | |
| DK185489D0 (da) | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse | |
| NO905520L (no) | Rifamycinderivater og fremgangsmaater for fremstilling av disse. | |
| NO912279L (no) | Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter. | |
| NO914654L (no) | Fremgangsmaate for fremstilling og anvendelse av beta-hydroksyetylaminer med 1,1-disubstituert cyklopropylrest | |
| FI942265L (fi) | 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| NO924444D0 (no) | Nitrogeninneholdende forbindelser, fremgangsmaate ved deres fremstilling og anvendelse av forbindelsene | |
| NO924069D0 (no) | Nitrogeninnholdige tetracykliske forbindelser med anti-allergisk og anti-astmatisk virkning, samt fremgangsmaate og anvendelse derav |